Chin W W, Shupnik M A, Ross D S, Habener J F, Ridgway E C
Endocrinology. 1985 Mar;116(3):873-8. doi: 10.1210/endo-116-3-873.
We studied the regulation of mRNAs encoding the alpha- and beta-subunits of TSH by thyroid hormones (T4 and T3) in mouse thyrotropic tumors and pituitary glands. Hypothyroid male (LAF1) mice bearing thyrotropic tumor (TtT97) were injected daily with T4 for 0, 1, 5, 12, or 33 days. After day 33, plasma levels of TSH and free (unassociated) TSH beta-subunit were reduced to less than 1% of control levels, whereas free alpha-subunit was reduced to 6% of control levels. Steady state levels of subunit mRNAs in extracts of the thyrotropic tissues were measured by blot hybridization analyses using mouse subunit-specific cloned cDNAs. Treatment of mice with T4 caused a rapid decline in the levels of tumor mRNAs for both alpha and TSH beta; after day 1, alpha and TSH beta mRNA levels decreased to 35% and 10% of control values, respectively. Levels of TSH beta mRNA were undetectable after 5 days of T4 treatment, whereas levels of alpha-subunit mRNA remained at 30-35% of control levels even after day 33. In a separate experiment, TSH beta mRNA decreased to 42% of the control level (P less than 0.05), whereas alpha-subunit mRNA remained at 64% of the control level (P = NS) 4 h after a single injection of T4. Finally, T3 also caused a rapid decrease in the levels of both subunit mRNAs in the anterior pituitary glands of hypothyroid mice, but the effect was more complete on TSH beta mRNA levels. We conclude that thyroid hormones have rapid suppressive effects on the levels of mRNAs encoding the subunits of mouse TSH in the thyrotrope. The suppressive effects of thyroid hormones occur more rapidly and are greater for TSH beta than alpha-subunit mRNAs. The parallel changes observed in the subunit mRNA levels and the plasma subunit protein levels in animals treated with thyroid hormones suggest that the changes in the plasma levels of TSH and subunits may reflect effects of thyroid hormones on TSH gene expression in addition to effects on secretion.
我们研究了甲状腺激素(T4和T3)对小鼠促甲状腺肿瘤和垂体中编码促甲状腺激素α和β亚基的mRNA的调控作用。对患有促甲状腺肿瘤(TtT97)的甲状腺功能减退雄性(LAF1)小鼠,每天注射T4,持续0、1、5、12或33天。33天后,促甲状腺激素和游离(未结合)促甲状腺激素β亚基的血浆水平降至对照水平的1%以下,而游离α亚基降至对照水平的6%。使用小鼠亚基特异性克隆cDNA,通过印迹杂交分析测定促甲状腺组织提取物中亚基mRNA的稳态水平。用T4处理小鼠导致肿瘤中α和促甲状腺激素β的mRNA水平迅速下降;第1天后,α和促甲状腺激素β的mRNA水平分别降至对照值的35%和10%。T4处理5天后,促甲状腺激素β的mRNA水平检测不到,而α亚基mRNA水平即使在33天后仍维持在对照水平的30 - 35%。在另一项实验中,单次注射T4后4小时,促甲状腺激素β的mRNA降至对照水平的42%(P < 0.05),而α亚基mRNA维持在对照水平的64%(P = 无显著性差异)。最后,T3也导致甲状腺功能减退小鼠垂体前叶中两个亚基的mRNA水平迅速下降,但对促甲状腺激素β的mRNA水平影响更彻底。我们得出结论,甲状腺激素对促甲状腺细胞中编码小鼠促甲状腺激素亚基的mRNA水平有快速抑制作用。甲状腺激素的抑制作用出现更快,对促甲状腺激素β的作用比对α亚基mRNA的作用更强。在用甲状腺激素处理的动物中,观察到亚基mRNA水平和血浆亚基蛋白水平的平行变化,这表明促甲状腺激素和亚基血浆水平的变化可能除了反映对分泌的影响外,还反映了甲状腺激素对促甲状腺激素基因表达的影响。